By Diagnostics World Staff
May 31, 2017 | Boston Healthcare and Data Information Intelligence (dii) today announced a new partnership to develop and commercialize life sciences data and analytics for biopharmaceutical, medical device, and diagnostic companies.
Boston Healthcare and dii will provide a joint offering for clients who need access to data and analytics across Europe, the Middle East, and the Americas. The offering includes access to data from over 7,000 hospitals and labs, with a focus on detailed insights on installations from over 2,400 hospitals and labs, and clinical diagnostics testing volumes, trends, systems, and reagents used for Molecular and IVD tests in over 1,500 labs.
Clinical diagnostics are increasing in importance and value as the development and demand for targeted, precision medicines grow. The partnership between Boston Healthcare and dii will provide biopharmaceutical, medical device, and diagnostic companies with unparalleled access to detailed datasets and customizable reports regarding the global market for diagnostic tests.